RecruitingNCT05886218

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery

Sponsor

University of California, Davis

Enrollment

215 participants

Start Date

Feb 8, 2023

Study Type

OBSERVATIONAL

Conditions

Sugammadex

Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Quantitative Neuromuscular Function Monitoring for people with sugammadex. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEQuantitative Neuromuscular Function Monitoring

Quantitative electromyographic (EMG) monitoring

Locations(1)

UC Davis Medical Center

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05886218

Related Trials

Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal

NCT069620071 location